SILVER SPRING, Md., June 3, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic's ...

MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

BrioHealth Solutions ( today announces the successful implantation of its 100th BrioVAD System, an investigational Ventricular Assist Device (VAD) designed to support patients with advanced heart ...

(RTTNews) - Medical devices maker Medtronic plc (MDT) will stop the distribution and sale of the Medtronic Heartware Ventricular Assist Device (HVAD) System. It has also notified physicians to cease ...

Pediatric ventricular assist devices (VADs) and mechanical circulatory support systems have emerged as critical tools in the management of children with end‐stage heart failure, including those with ...

The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic's Heartware Ventricular Assist Device (HVAD) System due to ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...

Health care providers should no longer use Medtronic’s Heartware Ventricular Assist Device (HVAD) System in end-stage heart failure patients. The Food and Drug Administration (FDA) is notifying health ...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...

The DuraHeart Left-Ventricular Assist System, or “LVAS,” from Terumo Heart was featured at a recent health technology event. DuraHeart LVAS is a next-generation medical device designed to help sustain ...